Physiological Dynamics in the Upper Gastrointestinal Tract and the Development of Gastrointestinal Absorption Models for the Immediate-Release Oral Dosage Forms in Healthy Adult Human

被引:3
|
作者
Wang, Kai [1 ]
Amidon, Gordon L. [1 ]
Smith, David E. [1 ]
机构
[1] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
关键词
gastrointestinal dynamics; intra-individual variability; machine learning; oral absorption model; within-subject variability; ZERO-ORDER ABSORPTION; IN-SILICO PREDICTION; DRUG ABSORPTION; AQUEOUS SOLUBILITY; VIVO DISSOLUTION; META-MODELS; TRANSIT; MOTILITY; MEAL; FOOD;
D O I
10.1007/s11095-023-03597-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This review is a revisit of various oral drug absorption models developed in the past decades, focusing on how to incorporate the physiological dynamics in the upper gastrointestinal (GI) tract. For immediate-release oral drugs, GI absorption is a critical input of drug exposure and subsequent human body response, yet difficult to model largely due to the complex GI environment. One of the biggest hurdles lies at capturing the high within-subject variability (WSV) of bioavailability measures, which can be mechanistically explained by the GI physiological dynamics. A thorough summary of how GI dynamics is handled in the absorption models would promote the development of mechanism-based oral drug absorption models, aid in the design of clinical studies regarding dosing regimens and bioequivalence studies based on WSV, and advance the decision-making on formulation selection.
引用
收藏
页码:2607 / 2626
页数:20
相关论文
共 11 条
  • [1] Physiological Dynamics in the Upper Gastrointestinal Tract and the Development of Gastrointestinal Absorption Models for the Immediate-Release Oral Dosage Forms in Healthy Adult Human
    Kai Wang
    Gordon L. Amidon
    David E. Smith
    Pharmaceutical Research, 2023, 40 : 2607 - 2626
  • [2] A Strategy for Quality Control Dissolution Method Development for Immediate-Release Solid Oral Dosage Forms
    Bredael, Gerard M.
    Liang, Steve
    Hahn, David
    DISSOLUTION TECHNOLOGIES, 2015, 22 (03): : 10 - 16
  • [3] GASTROINTESTINAL DYNAMICS AND PHARMACOLOGY FOR THE OPTIMUM DESIGN OF CONTROLLED-RELEASE ORAL DOSAGE FORMS
    READ, NW
    SUGDEN, K
    CRC CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1988, 4 (03): : 221 - 263
  • [4] Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers
    Podczeck, F.
    Course, N.
    Newton, J. M.
    Short, M. B.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (07) : 941 - 945
  • [5] In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions
    Koenigsknecht, Mark J.
    Baker, Jason R.
    Wen, Bo
    Frances, Ann
    Zhang, Huixia
    Yu, Alex
    Zhao, Ting
    Tsume, Yasuhiro
    Pai, Manjunath P.
    Bleske, Barry E.
    Zhang, Xinyuan
    Lionberger, Robert
    Lee, Allen
    Amidon, Gordon L.
    Hasler, William L.
    Sun, Duxin
    MOLECULAR PHARMACEUTICS, 2017, 14 (12) : 4295 - 4304
  • [6] In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage Forms
    James E. Polli
    The AAPS Journal, 2008, 10 : 289 - 299
  • [7] In-vitro evaluation of performance of solid immediate release dosage forms of weak bases in upper gastrointestinal lumen: experience with miconazole and clopidogrel salts
    Dimopoulou, Maria
    Mourouti, Canella-Stefania
    Vertzoni, Maria
    Symillides, Mira
    Reppas, Christos
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (05) : 579 - 587
  • [8] In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms
    Polli, James E.
    AAPS JOURNAL, 2008, 10 (02): : 289 - 299
  • [9] Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients
    Conrad, SA
    Gabrielli, A
    Margolis, B
    Quartin, A
    Hata, JS
    Frank, WO
    Bagin, RG
    Rock, JA
    Hepburn, B
    Laine, L
    CRITICAL CARE MEDICINE, 2005, 33 (04) : 760 - 765
  • [10] Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms
    Verwei, Miriam
    Minekus, Mans
    Zeijdner, Evelijn
    Schilderink, Ronald
    Havenaar, Robert
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 498 (1-2) : 178 - 186